Skip to main content
. 2022 Jun 24;10(7):1011. doi: 10.3390/vaccines10071011

Table 1.

Cohort demographics by vaccination status.

Full Cohort
(n = 119)
Unvaccinated
(n = 31)
Vaccinated
(n = 86)
p Value
Age
Median, IQR 47 (38–52) 38.5 (31–50.5) 48 (41–52) 0.002
Gender (n, %)
Male 76 (63.9) 18 (58.1) 58 (67.4) 0.7
Female 37 (31.1) 10 (32.3) 27 (31.4)
Unknown 6 (5.0) 3 (9.7) 1 (1.2)
Race (n, %)
White 102 (85.7) 24 (77.4) 78 (90.7) 0.4
Black 6 (5.0) 3 (9.7) 3 (3.5)
Other 3 (2.5) 1 (3.2) 2 (2.3)
Asian or Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0)
American Indian 1 (0.8) 0 (0.0) 1 (1.2)
Unknown 7 (5.9) 3 (9.7) 2 (2.3)
Previous SARS-CoV-2 infection (n, %)
Yes 41 (34.5) 13 (41.94) 28 (32.6) <0.001
No 45 (37.8) 3 (9.7) 42 (48.8)
I don’t know 26 (21.9) 12 (38.7) 14 (16.3)
No response 7 (5.9) 3 (9.7) 2 (2.3)
Any Comorbidity 48 (40.3) 9 (29.0) 39 (45.4) 0.2
Common Comorbidities
Hypertension (high blood pressure) 20 (16.8) 2 (6.5) 18 (21.0)
Asthma 7 (5.9) 1 (3.2) 6 (7.0)
Other autoimmune diseases 7 (5.9) 1 (3.2) 6 (7.0)
Cancer—current or past 6 (5.04) 1 (3.2) 5 (5.8)
Inflammatory bowel disease 5 (4.2) 1 (3.2) 4 (4.7)
Diabetes (any type) 3 (2.5) 1 (3.2) 2 (2.3)
Smoking Status
Never smoked 103 (86.55) 27 (87.1) 76 (88.37) 0.001
Current or former smoker 10 (8.4) 1 (3.23) 9 (10.47)
Missing 6 (5.04) 3 (9.68) 1 (1.16)